文献速递肝胆胰外科围术期管理与 ERAS

胰腺术后浅表与器官腔隙手术部位感染的危险因素区分

Distinction of Risk Factors for Superficial vs Organ-Space Surgical Site Infections After Pancreatic Surgery.
PubMed 文献 · JAMA Surg · 2017-01-01

单中心浅表SSI独立危险因素为术前胆道支架置入和免疫抑制性皮质类固醇使用,器官腔隙SSI唯一危险因素是胰腺质地柔软;NSQIP-HPB数据验证了术前胆道支架置入与浅表SSI的关联,并显示胰腺质地柔软与器官腔隙SSI关联更强。

要点

  • 术前胆道支架置入和皮质类固醇使用增加浅表SSI风险。
  • 胰腺质地柔软是器官腔隙SSI的独立危险因素。
  • 器官腔隙SSI与胰腺瘘及脓毒症、住院时间延长相关。

核心结论

  • 术前胆道支架置入和皮质类固醇使用增加浅表SSI风险,即使接受围术期哌拉西林-他唑巴坦治疗。
  • 器官腔隙SSI与胰腺瘘相关,而胰腺瘘不可调控。
  • 将不同亚型SSI作为单一总体率报告可能产生误导。

主要发现

  • 单中心201例中58例(28.9%)发生任何SSI,其中浅表SSI 28例(13.9%)、深部切口SSI 8例(4%)、器官腔隙SSI 24例(11.9%)。

临床怎么用

  • 对术前胆道支架置入或使用皮质类固醇的患者,可考虑延长广谱围术期抗生素治疗等额外措施。
  • 报告SSI时应区分浅表与器官腔隙亚型,避免单一总体率误导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Surgical site infection (SSI) rates are increasingly used as a quality metric. However, risk factors for SSI in pancreatic surgery remain undefined. OBJECTIVE: To stratify superficial and organ-space SSIs after pancreatectomy and investigate their modifiable risk factors. DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis included 201 patients undergoing pancreatic surgery at a university-based tertiary referral center from July 1, 2013, through June 30, 2015, and 10 371 patients from National Surgical Quality Improvement Program-Hepatopancreaticobiliary (NSQIP-HPB) Collaborative sites from January 1, 2014, through December 31, 2015. MAIN OUTCOMES AND MEASURES: Superficial, deep-incisional, and organ-space SSIs, as defined by NSQIP. RESULTS: Among the 201 patients treated at the single center (108 men [53.7%] and 93 women [46.3%]; median age, 48.6 years [IQR, 41.4-57.3 years]), 58 had any SSI (28.9%); 28 (13.9%), superficial SSI; 8 (4%), deep-incisional SSI; and 24 (11.9%), organ-space SSI. Independent risk factors for superficial SSI were preoperative biliary stenting (odds ratio [OR], 4.81; 95% CI, 1.25-18.56; P = .02) and use of immunosuppressive corticosteroids (OR, 13.42; 95% CI, 1.64-109.72; P = .02), whereas soft gland texture was the only risk factor for organ-space SSI (OR, 4.45; 95% CI, 1.35-14.66; P = .01). Most patients with organ-space infections also had grades B/C fistulae (15 of 24 [62.5%] vs 4 of 143 [2.8%] in patients with no SSI; P < .001). Organ/space but not superficial SSI was associated with an increased rate of sepsis (7 of 24 [29.2%] vs 4 of 143 [2.8%]; P < .001) and prolonged length of hospital stay (12 vs 8 days; P = .04). Among patients in the NSQIP-HPB Collaborative, 2057 (19.8%) had any SSI; 719 (6.9%), superficial SSI; 207 (2%), deep-incisional SSI; and 1287 (12.4%), organ-space SSI. Preoperative biliary stenting was confirmed as an independent risk factor for superficial SSI (OR, 2.07; 95% CI, 1.58-2.71; P < .001). In this larger data set, soft gland texture was an independent risk factor for superficial SSI (OR, 1.45; 95% CI, 1.14-1.85; P = .002) but was more strongly and significantly associated with organ-space SSI (OR, 2.32; 95% CI, 1.88-2.85; P < .001). CONCLUSIONS AND RELEVANCE: Preoperative biliary stenting and coriticosteroid use increase superficial SSI, even in patients receiving perioperative piperacillin-tazobactam. Additional measures, including extended broad-spectrum perioperative antibiotic treatment, should be considered in these patients. Organ/space SSIs appear to be related to pancreatic fistulae, which are not modifiable. Reporting these different subtypes as a single, overall rate may be misleading.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Elliott IA, Chan C, Russell TA, et al. Distinction of Risk Factors for Superficial vs Organ-Space Surgical Site Infections After Pancreatic Surgery. JAMA Surg. 2017. PMID: 28700780. doi:10.1001/jamasurg.2017.2155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。